Autek China Inc
SZSE:300595

Watchlist Manager
Autek China Inc Logo
Autek China Inc
SZSE:300595
Watchlist
Price: 14.42 CNY 0.91%
Market Cap: ¥12.9B

Autek China Inc
Selling, General & Administrative

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Autek China Inc
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Autek China Inc
SZSE:300595
Selling, General & Administrative
-¥555m
CAGR 3-Years
-16%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
S
Shanghai Conant Optical Co Ltd
HKEX:2276
Selling, General & Administrative
-¥335.9m
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Selling, General & Administrative
-¥1.1B
CAGR 3-Years
-8%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Selling, General & Administrative
-¥2.6B
CAGR 3-Years
-5%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Selling, General & Administrative
-¥793.2m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-19%
Intco Medical Technology Co Ltd
SZSE:300677
Selling, General & Administrative
-¥916m
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
No Stocks Found

Autek China Inc
Glance View

Market Cap
12.9B CNY
Industry
Health Care

Autek China Inc. stands as an emblematic figure in the dynamic landscape of medical devices and biotechnology in China. Rooted in its mission to innovate within the realms of diagnostic imaging and therapeutic ultrasound equipment, the company has maneuvered through this niche market by leveraging both cutting-edge technology and strategic partnerships. Autek's portfolio includes a range of high-quality ultrasound machines and imaging solutions that cater to the rapidly evolving needs of hospitals and clinics. By capitalizing on the growing demand for advanced healthcare services in China, Autek has tailored its product offerings to resonate with local market needs while maintaining competitive pricing strategies. This keen understanding of market dynamics allows Autek to maintain a robust sales pipeline and forge sturdy relationships within the medical community, driving its revenue growth engine. The company's operational blueprint hinges on an impressive blend of research-driven innovation and effective distribution networks. Autek continually invests in research and development, aspiring to push technological boundaries and uphold its reputation as a pioneer in the medical imaging sector. This investment lays the groundwork for creating state-of-the-art products that are not only technologically advanced but also user-friendly for medical professionals. Autek's adeptness at navigating regulatory landscapes ensures smooth market entry and expansion for its offerings. Furthermore, its strategic alliances with healthcare providers and government entities enhance its distribution network, ensuring that its products reach a wide spectrum of healthcare institutions across China. Autek makes its money by selling its technologically advanced and reliable devices, as well as providing ongoing support and maintenance services, forming the backbone of its revenue model and securing its position in the competitive arena.

Intrinsic Value
14.45 CNY
Fairly Valued
Intrinsic Value
Price ¥14.42

See Also

What is Autek China Inc's Selling, General & Administrative?
Selling, General & Administrative
-555m CNY

Based on the financial report for Dec 31, 2025, Autek China Inc's Selling, General & Administrative amounts to -555m CNY.

What is Autek China Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-19%

Over the last year, the Selling, General & Administrative growth was -13%. The average annual Selling, General & Administrative growth rates for Autek China Inc have been -16% over the past three years , -19% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett